Clinical Trials Logo

Recurrent Anal Cancer clinical trials

View clinical trials related to Recurrent Anal Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05055635 Recruiting - Anal Cancer Clinical Trials

Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)

ReRad III
Start date: July 7, 2021
Phase: Phase 2
Study type: Interventional

This protocol aims to determine toxicity and efficacy of re-irradiation for patients with recurrences from anal cancers with dose-escalated pencil beam proton therapy either pre-operative for marginally resectable recurrences or as a definitive treatment strategy (un-resectable, operation declined etc.). The over-all aim is to improve local tumor control with acceptable side effects.